Quest Diagnostics IncorporatedDGXNYSE
LOADING
|||
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +8.41% | +14.55% | +12.09% | +15.19% | +13.18% |
| Gross Profit Growth | +7.56% | +15.95% | +11.93% | +17.29% | +17.02% |
| EBITDA Growth | +6.21% | +29.34% | +13.23% | +24.69% | +14.20% |
| Operating Income Growth | -3.51% | +35.21% | +15.33% | +23.38% | +16.97% |
| Net Income Growth | +0.44% | +15.63% | +13.40% | +23.14% | +8.41% |
| EPS Growth | +1.01% | +15.12% | +13.22% | +22.44% | +8.46% |
| EPS Diluted Growth | +1.53% | +14.71% | +12.79% | +21.08% | +8.54% |
| Weighted Average Shares Growth | +0.00% | -0.89% | +0.00% | +0.90% | +0.00% |
| Weighted Average Shares Diluted Growth | -0.88% | +0.00% | +0.89% | +0.89% | +0.00% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +71.98% | -11.95% | +103.90% | +51.11% | +58.15% |
| Free Cash Flow Growth | +145.10% | -25.05% | +294.00% | +62.69% | +67.60% |
| Receivables Growth | +7.42% | +7.77% | +6.20% | +7.58% | +5.81% |
| Inventory Growth | +0.00% | -1.05% | +4.42% | +2.75% | +1.09% |
| Asset Growth | +19.38% | +15.20% | +13.21% | +15.04% | +0.63% |
| Book Value per Share Growth | +5.98% | +8.44% | +7.73% | +8.26% | +6.59% |
| Debt Growth | +41.90% | +28.98% | +22.76% | +25.47% | -8.44% |
| R&D Expense Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| SG&A Expenses Growth | +17.89% | +15.92% | +9.17% | +19.70% | +11.83% |